Battle of the 2 Titans | Round 2 - Sponsored by Lilly


Battle of the 2 Titans | Round 2
Challenging Patient Cases: Who is Eligible for Systemic Treatment in Atopic Dermatitis?

About the Meeting:

The goal of this program is to improve the recognition and the identification of patients that require long term control of their atopic dermatitis with a systemic therapy. Upon completion of this activity, participants will be able to identify the severity of atopic dermatitis, the disease burden, and the lack of treatment response in:

  • Patients with skin of color
  • Adolescents



Andrew Blauvelt, MD, MBA

Oregon Medical Research Center
Portland, OR, USA

Jonathan I. Silverberg, MD, PhD, MPH
Associate Director, Department of Dermatology

Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC, USA

@2023 Lilly USA, LLC. All rights reserved.